A detailed history of State Street Corp transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 33,700 shares of CPIX stock, worth $51,561. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,700
Previous 39,790 15.31%
Holding current value
$51,561
Previous $71,000 21.13%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.68 - $2.24 $10,231 - $13,641
-6,090 Reduced 15.31%
33,700 $56,000
Q3 2023

Nov 14, 2023

SELL
$1.43 - $2.3 $4,654 - $7,486
-3,255 Reduced 7.56%
39,790 $75,000
Q2 2022

Aug 15, 2022

BUY
$1.93 - $3.03 $1,930 - $3,030
1,000 Added 2.38%
43,045 $89,000
Q1 2022

May 16, 2022

SELL
$2.56 - $4.98 $60,787 - $118,250
-23,745 Reduced 36.09%
42,045 $119,000
Q4 2021

Feb 14, 2022

BUY
$2.2 - $6.94 $144,738 - $456,582
65,790 New
65,790 $307,000

Others Institutions Holding CPIX

About CUMBERLAND PHARMACEUTICALS INC


  • Ticker CPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 14,661,900
  • Market Cap $22.4M
  • Description
  • Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...
More about CPIX
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.